Advanced Filters
noise
Found 64,783 clinical trials
H Hector Guadalajara Labajo

Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients

Airborne nanoparticle exposure is increasingly recognized as a significant contributor to oxidative stress, mitochondrial dysfunction, and low-grade systemic inflammation-factors that impair postoperative recovery. The World Health Organization and European initiatives such as the Human Exposome Project have highlighted the clinical importance of the exposome, defined as the totality of environmental …

18 years of age All Phase 1/2

Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

The main objective is to evaluate the impact of a Regorafenib combined with metronomic chemotherapy (capecitabine and cyclophosphamide) and low-dose aspirin compared to standard Regorafenib treatment in patients with metastatic colorectal cancer by assessing progression-free survival.

18 years of age All Phase 2
M MAYAUX Julien, MD

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

ICU patients with severe hyponatremia and a high risk of rapid SNa overcorrection.

18 years of age All Phase 3

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

The purpose of this study is to learn about the safety and tolerability of a pneumococcal vaccine in adults. Participants will receive either: an experimental PG4 vaccine a PG4 vaccine comparator a standard 20vPnC vaccine comparator placebo. A placebo does not have any medicine in it but looks just like …

65 - 84 years of age All Phase 1
C Chiun Ho Hou, Ph.D

Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.

20 - 85 years of age All Phase 4
S Shuang Wei, MD

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

Lung cancer is the leading cause of morbidity and mortality in the world, of which 80%-85% are non-small cell lung cancer (NSCLC). Most patients with NSCLC are at the advanced stage of diagnosis and have a poor prognosis. The 5-year survival rate of stage III patients is about 15%, the …

18 years of age All Phase 1
C Chao Peng, Doctor

A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain

This study is designed to evaluate the safety and efficacy of GenSci048 for moderate to severe endometriosis-associated pain treatment.

18 - 49 years of age Female Phase 2
E Elizabeth McCracken, MS, CGC

Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

This is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD). The medication is triheptanoin, which is currently FDA approved for the treatment of long chain fatty acid oxidation disorders (FAODs). Previous research suggests …

4 years of age All Phase 2
A Athena Papas

Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser

The objective of the present randomized controlled trial is to evaluate the safety and efficacy of the use of Bixdo A30 Pro Ultra Compact Water Flosser (also referred to as the "Bixdo A30 Portable Water Flosser Travel Set") in addition to a manual toothbrush on clinical parameters of inflammation and …

18 - 70 years of age All Phase N/A
J Jaegu Kang

To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.

19 - 50 years of age All Phase 1

Simplify language using AI